Speaker illustration

Doctor Pierpaolo Pellicori

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

I am a clinical cardiologist currently working as a senior clinical research fellow in the Robertson Centre for Biostatistics at the University of Glasgow with an honorary consultant cardiologist contract with NHS Greater Glasgow and Clyde. I obtained my medical degree from Sapienza University in Rome and completed my specialist training in Cardiology in 2008 from the same institution. I spent my last 9 months of training abroad at a tertiary centre (RWTH University, Aachen, Germany) to improve my skills in advanced echocardiography. I subsequently worked for 6 months with an Italian Charity (Emergency) in Sudan and then applied for GMC registration before moving to the UK in 2010. Over the past ten years, I have combined both research and clinical duties. My current area of interest is the use of new imaging modalities as tool to quantify clinical congestion with greater precision.

Discussant review - EASY-HF

Event: Heart Failure 2024

Topic: Treatment

Session: Late breaking clinical trials: medical therapy

Thumbnail

Neutrophil-to-lymphocyte ratio: association with indices of congestion, inflammation, and mortality in outpatients with heart failure

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - epidemiology, prognosis, outcome 1

Thumbnail

The burden and pattern of comorbidities and its relation to mortality in frail vs non-frail patients with chronic heart failure

Event: ESC Congress 2022

Topic: Comorbidities

Session: Chroninc heart failure - Comorbidities

Thumbnail

Fluid responsiveness and congestion.

Event: EuroEcho 2019

Topic: Echocardiography, Other

Session: Non-invasive hemodynamic assessment in different contexts

Thumbnail

Body mass index or waist and hip circumference as predictors of outcome in the UK biobank

Event: ESC Congress 2019

Topic: Epidemiology

Session: New approaches in risk stratification

Thumbnail

Early benefits of empagliflozin in patients with type 2 diabetes with heart failure are not offset by increased adverse events: results from the EMPA-REG OUTCOME trial

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Heart failure: prognosis, outcome

Thumbnail

Relationship between congestion by ultrasound, body mass index and cardiac rhythm in ambulatory patients with heart failure

Event: Heart Failure 2019

Topic: Imaging

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

What proportion of patients with heart failure are candidates for sacubitril/valsartan? Differences between guideline recommendations and regulatory labels

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Chronic heart failure – Treatment

Thumbnail

HsCRP in patients with heart failure and its associations with outcome

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure – epidemiology, prognosis, outcome

Thumbnail

Relationship of clinical congestion to biomarker activation and outcome in patients with heart failure: findings from BIOSTAT-CHF

Event: Heart Failure 2018

Topic: Clinical

Session: Congestion: how to detect with new technologies

Thumbnail